Eligible patients , who were taking a strong opioid analgesic and had a mean pain intensity score < @ during the @ days prior to randomization ( adequate pain control on previous strong opioid ) , were randomized ( @:@ ) to receive twice-daily treatment with tapentadol ER ( @-@ mg/day ) or morphine sustained release ( SR ; @-@ mg/day ; reference for assay sensitivity ) .